Top

Diabetologia

Published in:

01-10-2007 | Article

Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats

Authors: D. R. Laybutt, Y. C. Hawkins, J. Lock, J. Lebet, A. Sharma, S. Bonner-Weir, G. C. Weir

Published in: Diabetologia | Issue 10/2007

Abstract

Aims/hypothesis

Hyperglycaemia can impair beta cell function after islet transplantation. Appropriate glucose-induced insulin secretion is dependent on a unique expression pattern of genes. Here we examined the effects of diabetes on gene expression in transplanted islets.

Materials and methods

Streptozotocin-induced diabetic or control non-diabetic Lewis rats were transplanted under the kidney capsule with an insufficient number (2,000) of syngeneic islets to normalise blood glucose levels in diabetic rats. Eighteen days after transplantation, islet grafts were retrieved and RT-PCR used to assess expression of selected genes critical for beta cell function. Islet grafts from diabetic rats transplanted with a sufficient number of islets (3,000) to normalise hyperglycaemia were used to assess the effects of correcting blood glucose levels. Additionally, gene expression of transplanted islets from non-diabetic rats was compared with freshly isolated islets.

Results

In islet grafts from diabetic rats, mRNA levels of several transcription factors important for the maintenance of beta cell differentiation were reduced (pancreatic and duodenal homeobox 1 [Pdx1], neurogenic differentiation 1 [Neurod1], NK6 transcription factor related, locus 1 [Nkx6.1], paired box gene 6 [Pax6]), as were genes implicated in beta cell function (Glut2 [also known as solute carrier family 2 [facilitated glucose transporter], member 2 [Slc2a2], glucokinase, insulin, islet amyloid polypeptide [Iapp]). Conversely, mRNA levels of lactate dehydrogenase, which is normally suppressed in beta cells, were increased. The majority of the changes in gene expression were normalised after correction of hyperglycaemia, indicating that the severe loss of beta cell differentiation correlates with continuous exposure to diabetes. Even islet grafts from non-diabetic rats showed a few alterations in beta cell gene expression in comparison with fresh islets.

Conclusions/interpretation

Chronic hyperglycaemia contributes to the deterioration of beta cell differentiation after islet transplantation.

Available only for authorised users

Brunzell JD, Robertson RP, Lerner RL et al (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42:222–229PubMedCrossRef

Porte D Jr (1991) Beta-cells in type II diabetes mellitus. Diabetes 40:166–180PubMedCrossRef

McCulloch DK, Klaff LJ, Kahn SE et al (1990) Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes 39:549–556PubMedCrossRef

Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368PubMedCrossRef

Gray DW, Cranston D, McShane P, Sutton R, Morris PJ (1989) The effect of hyperglycaemia on pancreatic islets transplanted into rats beneath the kidney capsule. Diabetologia 32:663–667PubMedCrossRef

Ogawa Y, Noma Y, Davalli AM et al (1995) Loss of glucose-induced insulin secretion and GLUT2 expression in transplanted beta-cells. Diabetes 44:75–79PubMedCrossRef

Korsgren O, Jansson L, Sandler S, Andersson A (1990) Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J Clin Invest 86:2161–2168PubMedCrossRef

Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238PubMedCrossRef

Alejandro R, Cutfield RG, Shienvold FL et al (1986) Natural history of intrahepatic canine islet cell autografts. J Clin Invest 78:1339–1348PubMed

10.

Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC (1996) Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45:1161–1167PubMedCrossRef

11.

Mattsson G, Jansson L, Nordin A, Andersson A, Carlsson PO (2004) Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes 53:948–954PubMedCrossRef

12.

Montana E, Bonner-Weir S, Weir GC (1993) Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozotocin diabetic C57BL/6 mice. J Clin Invest 91:780–787PubMed

13.

Shi CL, Taljedal IB (1996) Dynamics of glucose-induced insulin release from mouse islets transplanted under the kidney capsule. Transplantation 62:1312–1318PubMedCrossRef

14.

Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060–2069PubMedCrossRef

15.

Juang JH, Bonner-Weir S, Wu YJ, Weir GC (1994) Beneficial influence of glycemic control upon the growth and function of transplanted islets. Diabetes 43:1334–1339PubMedCrossRef

16.

Ar’Rajab A, Ahren B (1992) Prevention of hyperglycemia improves the long-term result of islet transplantation in streptozotocin-diabetic rats. Pancreas 7:435–442PubMedCrossRef

17.

Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E (2002) Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51:66–72PubMedCrossRef

18.

Lopez-Nieto CE, You G, Bush KT, Barros EJ, Beier DR, Nigam SK (1997) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272:6471–6478PubMedCrossRef

19.

Jonas JC, Sharma A, Hasenkamp W et al (1999) Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 274:14112–14121PubMedCrossRef

20.

Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC (2002) Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 277:10912–10921PubMedCrossRef

21.

Tokuyama Y, Sturis J, DePaoli AM et al (1995) Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447–1457PubMedCrossRef

22.

Thorens B, Wu YJ, Leahy JL, Weir GC (1992) The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. J Clin Invest 90:77–85PubMed

23.

Laybutt DR, Glandt M, Xu G et al (2003) Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 278:2997–3005PubMedCrossRef

24.

Kjorholt C, Akerfeldt MC, Biden TJ, Laybutt DR (2005) Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes 54:2755–2763PubMedCrossRef

25.

Huang HP, Tsai MJ (2000) Transcription factors involved in pancreatic islet development. J Biomed Sci 7:27–34PubMedCrossRef

26.

Schwitzgebel VM, Scheel DW, Conners JR et al (2000) Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 127:3533–3542PubMed

27.

Servitja JM, Ferrer J (2004) Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 47:597–613PubMedCrossRef

28.

Menger MD, Jaeger S, Walter P, Feifel G, Hammersen F, Messmer K (1989) Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 38(Suppl 1):199–201PubMed

29.

Vasir B, Reitz P, Xu G, Sharma A, Bonner-Weir S, Weir GC (2000) Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-α, TGF-β, bFGF and vimentin) in cultured and transplanted rat islets. Diabetologia 43:763–772PubMedCrossRef

30.

Dionne KE, Colton CK, Yarmush ML (1993) Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 42:12–21PubMedCrossRef

Title: Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats
Authors: D. R. Laybutt
Y. C. Hawkins
J. Lock
J. Lebet
A. Sharma
S. Bonner-Weir
G. C. Weir
Publication date: 01-10-2007
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 10/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-007-0749-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aims/hypothesis

Materials and methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 10/2007

Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study

Mutations in the SLC30A8 gene are not a major cause of MODY or other forms of early-onset, autosomal dominant type 2 diabetes

An adenylate kinase is involved in KATP channel regulation of mouse pancreatic beta cells

Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials